TCL Archive Guest Editorial: Richard Schilsky Reflects On His Past Decade WithThe Board of Scientific Advisors June 24, 2011
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012